GoodRx Holdings (GDRX) Current Assets (2019 - 2026)

GoodRx Holdings has disclosed Current Assets across 8 years of filings, most recently posting $1.6 billion for Q2 2026.

• In Q2 2026, Current Assets rose 190.46% year-over-year to $1.6 billion; the TTM figure through Jun 2026 stood at $1.6 billion (up 190.46% YoY), while the FY2025 annual figure was $643.1 million, down 2.45% from the prior year.
• Current Assets came in at $1.6 billion for Q2 2026 at GoodRx Holdings, up from $1.3 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.6 billion in Q2 2026 to a low of $540.2 million in Q1 2025.
• Average Current Assets over 5 years is $849.4 million, with a median of $875.6 million recorded in 2022.
• Year-over-year, Current Assets sank 35.32% in 2024 and jumped 190.46% in 2026.
• Over 5 years, Current Assets stood at $919.7 million in 2022, then declined by 5.1% to $872.8 million in 2023, then decreased by 24.47% to $659.3 million in 2024, then retreated by 2.45% to $643.1 million in 2025, then jumped by 148.69% to $1.6 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $1.6 billion in Q2 2026, $1.3 billion in Q1 2026, and $643.1 million in Q4 2025.